Business Card for Susan Story:


Director, Hris
New York City, NY area
Email Avail: 3 Day Free Trial


900 Ridgebury Rd
Ridgefield, CT 06877

Tel: (203) 798-9988

Last updated on 2017-12-10


About Susan Story:

Susan Story works as an Director, Hris for Boehringer Ingelheim GmbH at New York City, NY. The company's webpage is http://www.boehringer-ingelheim.com. For email, phone number and executive profiles for Director, Hris and other executives of Boehringer Ingelheim GmbH at New York City, NY, check Boehringer Ingelheim GmbH at Joesdata.com. Not the Susan Story you are looking for? Do a quick search in our website and find other people named Susan Story.
Susan Story's Work History:
No information available..

Susan Story's Education:
No information available..

Susan Story's Co-workers:
As of September 25, 2021, Susan Story has 527 co-workers under the company name Boehringer Ingelheim GmbH at Joesdata.com.

About Boehringer Ingelheim GmbH:

Boehringer Ingelheim GmbH is located at 900 Ridgebury Rd , Ridgefield, CT 06877. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-17 19:18:47
Large European real-world study reports effects of Spiolto Respimat for people living with COPD in daily clinical practice1
2018-09-13 17:49:03
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
2018-09-13 17:12:15
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
2018-09-04 18:00:25
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
2018-09-04 17:30:29
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
2018-08-20 18:25:00
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa (dabigatran etexilate)
2018-08-20 17:30:45
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa (dabigatran etexilate)
2018-08-06 17:30:49
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
2018-08-06 17:06:30
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
2018-08-02 17:06:30
Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa

People in the same industry:

Bradley Marr
Director, QA and Regulatory Compliance
New Chapter, Inc.

Rene Bloemke
Manager Pharmacy Services
Net-Rx

Erica Egizi
Operations Manager
TB Alliance

Lori Carlin
Information Technology Manager
Altegra Health

Daniel Bitler
Quality Assurance and Regulatory Manager
Wedgewood Pharmacy

Michael Theodore Nicolaides
Manager of Information Technology and Property
SNBL Clinical Pharmacology Center, Inc.